PuSH - Publikationsserver des Helmholtz Zentrums München

Studying OTUD6B-OTUB1 protein-protein interaction by low-throughput GFP-trap assays and high-throughput AlphaScreen assays.

In: Proteomic Profiling. Berlin [u.a.]: Springer, 2021. 381-394 (Methods Mol. Biol. ; 2261)
Postprint DOI PMC
Open Access Green
Protein-protein interactions (PPI) are involved in a myriad of cellular processes, and their deregulation can lead to many diseases. One such process is protein ubiquitination that requires an orchestrated action of three key enzymes to add ubiquitin moieties to substrate proteins. Importantly, this process is reversible through deubiquitinating enzymes. Both ubiquitination and deubiquitination require many PPIs that once classified can be utilized to identify small molecule inhibitors counteracting these reactions. Here, we study the protein-protein interaction between the two deubiquitinating enzymes OTUB1 and OTUD6B and report for the first time that both proteins directly interact with each other. We describe the GFP-Trap immunoprecipitation as a cell-based method to analyze the OTUD6B-OTUB1 interaction in the cellular context and the AlphaScreen (amplified luminescent proximity homogeneous assay) assay as a tool to detect direct interactions and to search for PPI inhibitors.
Altmetric
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Sammelbandbeitrag/Buchkapitel
Schlagwörter Alphascreen ; Deubiquitinase ; Dub ; Gfp-trap ; Homogeneous Proximity Assay ; Immunoprecipitation ; Otub1 ; Otud6b ; Protein–protein Interactions ; Ubiquitin
Sprache englisch
Veröffentlichungsjahr 2021
HGF-Berichtsjahr 2021
ISSN (print) / ISBN 1064-3745
e-ISSN 1940-6029
Bandtitel Proteomic Profiling
Quellenangaben Band: 2261, Heft: , Seiten: 381-394 Artikelnummer: , Supplement: ,
Verlag Springer
Verlagsort Berlin [u.a.]
Begutachtungsstatus Peer reviewed
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Enabling and Novel Technologies
PSP-Element(e) G-505293-001
Scopus ID 85099721831
PubMed ID 33421002
Erfassungsdatum 2021-03-30